about
Nonpharmacologic management of behavioral symptoms in dementiaMolecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric DisordersAlzheimer's Disease associated with Psychiatric ComorbiditiesPsychosis in Alzheimer's diseaseNeuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the futureManagement of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panelManaging anxiety associated with neurodegenerative disordersWhy looking at the whole hippocampus is not enough-a critical role for anteroposterior axis, subfield and activation analyses to enhance predictive value of hippocampal changes for Alzheimer's disease diagnosis.Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?What can triumphs and tribulations from drug research in Alzheimer's disease tell us about the development of psychotropic drugs in general?Assessment and management of behavioral and psychological symptoms of dementiaEnhancing Communication in Adults with Dementia and Age-Related Hearing Loss.Neuropsychiatric effects of neurodegeneration of the medial versus lateral ventral prefrontal cortex in humansClinical and Demographic Factors Associated with the Cognitive and Emotional Efficacy of Regular Musical Activities in Dementia.Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series.WeCareAdvisor™: The Development of a Caregiver-focused, Web-based Program to Assess and Manage Behavioral and Psychological Symptoms of Dementia.White matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies.Personality and risk of Alzheimer's disease: new data and meta-analysis.Dysfunction of ventrolateral striatal dopamine receptor type 2-expressing medium spiny neurons impairs instrumental motivation.Elevated emotional contagion in a mouse model of Alzheimer's disease is associated with increased synchronization in the insula and amygdalaAerobic exercise improves quality of life, psychological well-being and systemic inflammation in subjects with Alzheimer's disease.Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer diseaseComputer-Based Training Programs for Older People with Mild Cognitive Impairment and/or Dementia.The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onsetBehavioral and psychological symptoms in Alzheimer's disease.Neuropsychiatric symptoms in Alzheimer's disease are related to functional connectivity alterations in the salience network.Total cholesterol and neuropsychiatric symptoms in Alzheimer's disease: the impact of total cholesterol level and gender.The role of the occupational therapist in the management of neuropsychiatric symptoms of dementia in clinical settings.Pharmacological and Nonpharmacological Treatment for Apathy in Alzheimer Disease : A systematic review across modalitiesThe monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's disease.Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design.Pharmacotherapy of neuropsychiatric symptoms of dementiaComprehensive gene- and pathway-based analysis of depressive symptoms in older adults.Assessing neuropsychiatric symptoms in people with dementia: a systematic review of measures.Sleep-Wake Cycle Dysfunction in the TgCRND8 Mouse Model of Alzheimer's Disease: From Early to Advanced Pathological Stages.A systematic review of strategies to foster activity engagement in persons with dementiaEvaluation of a hospital-based day-structuring exercise programme on exacerbated behavioural and psychological symptoms in dementia--the exercise carrousel: study protocol for a randomised controlled trial.Personal Strengths and Health Related Quality of Life in Dementia Caregivers from Latin AmericaDirect medical costs and source of cost differences across the spectrum of cognitive decline: a population-based study.Progress in Treatment Development for Neuropsychiatric Symptoms in Alzheimer's Disease: Focus on Agitation and Aggression. A Report from the EU/US/CTAD Task Force.
P2860
Q24598981-816179EA-833C-410E-A10D-4F55BAF6AD2EQ26766487-CB60025E-3190-4484-921F-D5328A0F64C5Q26796602-6C8CCB5D-158F-46B9-B22B-5D5078D38782Q26824635-33D0615F-2FE8-485A-B9DC-9602F157CB73Q26864905-4468F00D-1592-494E-BBF1-10D36A52ECE3Q26864923-6FA9C1D6-8C24-4777-BF00-9C769DF6157CQ27024451-02D5026B-C568-4C47-A366-41AE6ACE8D05Q27692592-91290BC4-9A65-41A7-8963-C4AB12CD3592Q28070156-384A1EF7-46EA-43E3-AEC9-F71AD32CA293Q28083481-4151E239-F482-43C0-825C-F9CC35C47B3FQ28088782-AB4C83FD-8E96-44C4-9F2C-1EF73484973CQ30234416-3EA73166-2655-443C-B149-D9FE75A7A5AFQ30368574-90235010-4C64-4620-A226-44001CB92DA7Q30380874-8B590CC9-013E-49D2-9251-7459D16809C5Q30400013-27860D5D-520F-487D-86D4-64E261CFF4FDQ30490340-A04CBD04-3334-49C0-B354-A91157565AECQ30620060-88CF8700-98C8-4326-8A42-E22D8EEDB9C7Q30632736-3F2AF229-0CEB-464B-BB08-6F30DC60182DQ30837855-BEA0262F-D319-4683-B656-60078DDD9298Q30844521-D5B5F96F-3EA3-493D-8E91-4C169B58B611Q33584348-F1C07430-68BC-411C-A34C-DC945D0ED102Q33644324-820FB5FC-92D5-412C-9FB5-CFB5D6C7F8DBQ33689792-FA894C41-C1C8-455B-91B7-A04A140CC838Q33873941-690DD2AA-4031-470A-B551-461857B1AD65Q34009796-B8D824BC-0BFD-4A45-9DA3-BF9070207715Q34328295-02D97FE7-4035-4071-AC52-8BC5C957DDA8Q34364200-2C354871-ACF4-47FE-8DB7-795D1A219A5CQ34402997-F8AA4EF4-F072-434E-B4D6-370AA7B2C950Q34552380-A7FB6BAD-0B31-44F4-99FE-2BAAEB95209CQ35119259-E191D0B3-5BE2-485E-B57F-12AB55204BB1Q35185368-935E3C35-5552-46D1-9F9E-51A92279F0E8Q35229781-E2E7C4D3-2789-4824-95CE-FC5F982D77CEQ35434690-FA4ABE4B-2D52-4B68-ADDD-7FC987B208D7Q35619443-C8AD7E39-CFCC-4937-A24B-0B840C612D1BQ35664166-2CF5344F-22F8-47F8-9115-AFD7797A6FF0Q35679639-A29D02BE-600B-4B2C-BA02-48CE2F50B823Q35737687-4D7E81F5-55EF-453C-8CEF-06F850E752E4Q35804300-82676A11-2B4F-4D69-8987-64B953260CA1Q35977886-28302318-E699-42FF-8597-18E2D9392774Q36087892-DD576714-FFF0-4A3A-B6F6-C0CCD58C894B
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Neuropsychiatric symptoms in Alzheimer's disease
@ast
Neuropsychiatric symptoms in Alzheimer's disease
@en
type
label
Neuropsychiatric symptoms in Alzheimer's disease
@ast
Neuropsychiatric symptoms in Alzheimer's disease
@en
prefLabel
Neuropsychiatric symptoms in Alzheimer's disease
@ast
Neuropsychiatric symptoms in Alzheimer's disease
@en
P2093
P2860
P1476
Neuropsychiatric symptoms in Alzheimer's disease
@en
P2093
Constantine G Lyketsos
David S Miller
J Michael Ryan
Jesse Cedarbaum
Joan Amatniek
Paula Trzepacz
Robert Brashear
P2860
P304
P356
10.1016/J.JALZ.2011.05.2410
P577
2011-09-01T00:00:00Z